Correction: Parkinson’s disease-associated genetic variation is linked to quantitative expression of inflammatory genes (PLoS One (2017) 12:4 (e0175882) DOI: 10.1371/journal.pone.0175882);Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes

PLoS ONE

Volumn 12, Issue 4, 2017, Pages

  Pierce, Steven ^a   Coetzee, Gerhard A ^a  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CORRELATIONAL STUDY; DISEASE ASSOCIATION; GENE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC RISK; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HLA MHC II GENE; HUMAN; PARKINSON DISEASE; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS;

HLA ANTIGEN CLASS 2;

GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LINKAGE DISEQUILIBRIUM; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI;

EID: 85017534145     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0210931     Document Type: Erratum

References (31)

1. Driver JA, Logroscino G, Gaziano JM, Kurth T. Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology. 2009;72(5):432-8. PubMed Central PMCID: PMCPMC2676726. https://doi.org/10.1212/01.wnl.0000341769.50075.bb PMID: 19188574
2. Labbe C, Lorenzo-Betancor O, Ross OA. Epigenetic regulation in Parkinson's disease. Acta Neuropathol. 2016;132(4):515-30. PubMed Central PMCID: PMCPMC5026906. https://doi.org/10.1007/s00401-016-1590-9 PMID: 27358065
3. Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet. 2014;46(9):989-93. PubMed Central PMCID: PMCPMC4146673. https://doi.org/10.1038/ng.3043 PMID: 25064009
4. Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 2014;42(Database issue):D1001-6. PubMed Central PMCID: PMCPMC3965119. https://doi.org/10.1093/nar/gkt1229 PMID: 24316577
5. Soldner F, Stelzer Y, Shivalila CS, Abraham BJ, Latourelle JC, Barrasa MI, et al. Parkinson-associated risk variant in distal enhancer of alpha-synuclein modulates target gene expression. Nature. 2016;533(7601):95-9. PubMed Central PMCID: PMCPMC5042324. https://doi.org/10.1038/nature17939 PMID: 27096366
6. Coetzee SG, Pierce S, Brundin P, Brundin L, Hazelett DJ, Coetzee GA. Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology. Sci Rep. 2016;6:30509. PubMed Central PMCID: PMCPMC4962314. https://doi.org/10.1038/srep30509 PMID: 27461410
7. Consortium GT. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45(6):580-5. PubMed Central PMCID: PMCPMC4010069. https://doi.org/10.1038/ng.2653 PMID: 23715323
8. Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, Yearout D, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet. 2010;42(9):781-5. PubMed Central PMCID: PMCPMC2930111. https://doi.org/10.1038/ng.642 PMID: 20711177
9. International Parkinson Disease Genomics C, Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet. 2011;377(9766):641-9. PubMed Central PMCID: PMCPMC3696507. https://doi.org/10.1016/S0140-6736 (10) 62345-8 PMID: 21292315
10. Kannarkat GT, Cook DA, Lee JK, Chang J, Chung J, Sandy E, et al. Common Genetic Variant Association with Altered HLA Expression, Synergy with Pyrethroid Exposure, and Risk for Parkinson's Disease: An Observational and Case-Control Study. NPJ Parkinsons Dis. 2015;1. PubMed Central PMCID: PMCPMC4853162.
11. Wang Q, Liu Y, Zhou J. Neuroinflammation in Parkinson's disease and its potential as therapeutic target. Transl Neurodegener. 2015;4:19. PubMed Central PMCID: PMCPMC4603346. https://doi.org/10. 1186/s40035-015-0042-0 PMID: 26464797
12. Khan A, Zhang X. dbSUPER: a database of super-enhancers in mouse and human genome. Nucleic Acids Res. 2016;44(D1):D164-71. PubMed Central PMCID: PMCPMC4702767. https://doi.org/10. 1093/nar/gkv1002 PMID: 26438538
13. Niederriter AR, Varshney A, Parker SC, Martin DM. Super Enhancers in Cancers, Complex Disease, and Developmental Disorders. Genes (Basel). 2015;6(4):1183-200. PubMed Central PMCID: PMCPMC4690034.
14. Quang DX, Erdos MR, Parker SC, Collins FS. Motif signatures in stretch enhancers are enriched for diseaseassociated genetic variants. Epigenetics Chromatin. 2015;8:23. PubMed Central PMCID: PMCPMC4502539. https://doi.org/10.1186/s13072-015-0015-7 PMID: 26180553
15. Coetzee SG, Coetzee GA, Hazelett DJ. motifbreakR: an R/Bioconductor package for predicting variant effects at transcription factor binding sites. Bioinformatics. 2015;31(23):3847-9. PubMed Central PMCID: PMCPMC4653394. https://doi.org/10.1093/bioinformatics/btv470 PMID: 26272984
16. Huang Da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44-57. https://doi.org/10.1038/nprot.2008.211 PMID: 19131956
17. Mi H, Poudel S, Muruganujan A, Casagrande JT, Thomas PD. PANTHER version 10: expanded protein families and functions, and analysis tools. Nucleic Acids Res. 2016;44(D1): D336-42. PubMed Central PMCID: PMCPMC4702852. https://doi.org/10.1093/nar/gkv1194 PMID: 26578592
18. Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BM, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet. 2012;8(3):e1002548. PubMed Central PMCID: PMCPMC3305333. https://doi.org/10.1371/journal.pgen. 1002548 PMID: 22438815
19. Latourelle JC, Dumitriu A, Hadzi TC, Beach TG, Myers RH. Evaluation of Parkinson disease risk variants as expression-QTLs. PLoS One. 2012;7(10):e46199. PubMed Central PMCID: PMCPMC3465315. https://doi.org/10.1371/journal.pone.0046199 PMID: 23071545
20. Li JQ, Tan L, Yu JT. The role of the LRRK2 gene in Parkinsonism. Mol Neurodegener. 2014;9:47. PubMed Central PMCID: PMCPMC4246469. https://doi.org/10.1186/1750-1326-9-47 PMID: 25391693
21. Skibinski G, Nakamura K, Cookson MR, Finkbeiner S. Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies. J Neurosci. 2014;34(2):418-33. PubMed Central PMCID: PMCPMC3870929. https://doi.org/10.1523/JNEUROSCI.2712-13.2014 PMID: 24403142
22. Tsika E, Moore DJ. Mechanisms of LRRK2-mediated neurodegeneration. Curr Neurol Neurosci Rep. 2012;12(3):251-60. https://doi.org/10.1007/s11910-012-0265-8 PMID: 22441981
23. Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48(5):481-7. https://doi.org/10.1038/ng.3538 PMID: 27019110
24. Foulger RE, Denny P, Hardy J, Martin MJ, Sawford T, Lovering RC. Using the Gene Ontology to Annotate Key Players in Parkinson's Disease. Neuroinformatics. 2016;14(3):297-304. PubMed Central PMCID: PMCPMC4896971. https://doi.org/10.1007/s12021-015-9293-2 PMID: 26825309
25. Michalopoulos I, Pavlopoulos GA, Malatras A, Karelas A, Kostadima MA, Schneider R, et al. Human gene correlation analysis (HGCA): a tool for the identification of transcriptionally co-expressed genes. BMC Res Notes. 2012;5:265. PubMed Central PMCID: PMCPMC3441226. https://doi.org/10.1186/1756-0500-5-265 PMID: 22672625
26. Holmans P, Moskvina V, Jones L, Sharma M, International Parkinson's Disease Genomics C, Vedernikov A, et al. A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease. Hum Mol Genet. 2013;22(5):1039-49. PubMed Central PMCID: PMCPMC3561909. https://doi.org/10.1093/hmg/dds492 PMID: 23223016
27. Zhao Y, Forst CV, Sayegh CE, Wang IM, Yang X, Zhang B. Molecular and genetic inflammation networks in major human diseases. Mol Biosyst. 2016;12(8):2318-41. PubMed Central PMCID: PMCPMC4955784. https://doi.org/10.1039/c6mb00240d PMID: 27303926
28. Rocha NP, De Miranda AS, Teixeira AL. Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies. Biomed Res Int. 2015;2015:628192. PubMed Central PMCID: PMCPMC4532803. https://doi.org/10.1155/2015/628192 PMID: 26295044
29. Hirsch EC, Vyas S, Hunot S. Neuroinflammation in Parkinson's disease. Parkinsonism Relat Disord. 2012;18 Suppl 1:S210-2.
30. Harms AS, Cao S, Rowse AL, Thome AD, Li X, Mangieri LR, et al. MHCII is required for alpha-synucleininduced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J Neurosci. 2013;33(23):9592-600. PubMed Central PMCID: PMCPMC3903980. https://doi.org/10. 1523/JNEUROSCI.5610-12.2013 PMID: 23739956
31. Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. The Central Nervous System and the Gut Microbiome. Cell. 2016;167(4):915-32. PubMed Central PMCID: PMCPMC5127403. https://doi.org/10.1016/j.cell.2016.10.027 PMID: 27814521